Literature DB >> 31872783

Why the first self-binding peptide of human c-Src kinase does not contain class II motif but can bind to its cognate Src homology 3 domain in class II mode?

Peng Zhou1,2,3, Fugang Yan1,2, Qingqing Miao1,2, Zheng Chen1,2, Heyi Wang1,2.   

Abstract

Src homology 3 (SH3) domains are small protein modules involved in the regulation of important cellular pathways such as proliferation and migration, which canonically prefer to recognize and interact with proline-rich peptide ligands with class I or class II motif. Previously, we identified two self-binding peptides (SBPs) in human c-Src tyrosine kinase, of which the first SBP (fSBP) segment (248SKPQTQGLAK257) fulfills intramolecular interaction with the kinase SH3 domain to regulate the kinase function. The segment (and its equivalents in other c-Src family members) does not contain canonical class II motif (PxxQxL versus PxxPx+), but can bind to SH3 domain in a routine class II mode. Existing theories such as non-polyproline-II binding conformation, unusual peptide-binding pocket and extensive use of contacts cannot explain this atypical recognition phenomenon. Here, we performed a systematic investigation of SH3-fSBP binding in different conditions, including the segment in full-length kinase or in isolated state, the kinase in different forms and the fSBP residue mutations, by using microsecond molecular dynamics simulations, conformational clustering analyses and binding energetics calculations. We purposed a new mechanism that the protein context is primarily responsible for the atypical intramolecular SH3-fSBP recognition in c-Src kinase, which can promote the tight packing of segment against domain surface, support the segment polyproline-II (PPII) conformation in unbound state, and avoid unfavorable segment interactions with SH3 charged region by forming a C-terminal t-turn. In addition, the only proline residue Pro250 of fSBP segment is also required for the segment recognition by SH3 domain in c-Src kinase context; lack of Pro250 residue the segment exhibits considerable disorder and cannot maintain in PPII helical conformation, thus largely impairing the domain-segment binding capability. Further binding analysis confirms that the isolated fSBP peptide cannot bind effectively to SH3 domain out of kinase context, whereas its mutant version, i.e. fSBP(Q253P/L255R) peptide, which possesses the canonical class II motif, exhibits an increased affinity to the domain.Communicated by Ramaswamy H. Sarma.

Entities:  

Keywords:  SH3 domain; Self-binding peptide; class II motif; domain–peptide recognition; human c-Src kinase; intramolecular interaction; protein context

Mesh:

Substances:

Year:  2020        PMID: 31872783     DOI: 10.1080/07391102.2019.1709547

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  4 in total

1.  Comprehensive binary interaction mapping of τ phosphotyrosine sites with SH2 domains in the human genome: Implications for the rational design of self-inhibitory phosphopeptides to target τ hyperphosphorylation signaling in Alzheimer's Disease.

Authors:  Zhonglei Bao; Jianghua Liu; Jin Fu
Journal:  Amino Acids       Date:  2022-05-27       Impact factor: 3.520

2.  Systematic analysis and molecular profiling of EGFR allosteric inhibitor cross-reactivity across the proto-oncogenic ErbB family kinases by integrating dynamics simulation, energetics calculation and biochemical assay.

Authors:  Yanli Ma; Bingli Qi; Meiying Ning; Lijuan Zhang; Zeyu An; Jing Zhao
Journal:  Eur Biophys J       Date:  2022-03-21       Impact factor: 1.733

3.  Molecular insight into the affinity, specificity and cross-reactivity of systematic hepatocellular carcinoma RALT interaction profile with human receptor tyrosine kinases.

Authors:  Guang Lu; Xiaoping Li; Jun Zhang; Qinghua Xu
Journal:  Amino Acids       Date:  2021-10-07       Impact factor: 3.520

4.  Structural Mapping of BMP Conformational Epitopes and Bioengineering Design of Osteogenic Peptides to Specifically Target the Epitope-Binding Sites.

Authors:  Hao Chen; Yaodong Zhou; Qirong Dong
Journal:  Cell Mol Bioeng       Date:  2022-04-28       Impact factor: 3.337

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.